These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 6376908)

  • 1. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonic requirements of Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Med Microbiol; 1986 Aug; 22(1):1-7. PubMed ID: 3735386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain differences in the opsonisation of Staphylococcus epidermidis.
    Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
    Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Warady BA; Campoy SF; Gross SP; Sedman AB; Lum GM
    J Pediatr; 1984 Nov; 105(5):726-30. PubMed ID: 6502302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium.
    Piraino B; Bernardini J; Holley JL; Perlmutter JA
    Am J Kidney Dis; 1992 Apr; 19(4):371-4. PubMed ID: 1562027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K; de Fijter CW; Bos HJ; van der Meulen J; Beelen RH; Oe PL; Verbrugh HA
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set.
    Holley JL; Bernardini J; Piraino B
    Am J Kidney Dis; 1994 Apr; 23(4):569-73. PubMed ID: 8154494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous cycling peritoneal dialysis is associated with lower rates of catheter infections than continuous ambulatory peritoneal dialysis.
    Holley JL; Bernardini J; Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):133-6. PubMed ID: 2382649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized lymphadenopathy in continuous ambulatory peritoneal dialysis patients associated with Staphylococcus epidermidis infection.
    Pollock CA; Ibels LS
    Nephron; 1989; 52(1):81-2. PubMed ID: 2710271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients.
    Locatelli AJ; Marcos GM; Gómez MG; Alvarez SA; DeBenedetti LC
    Adv Perit Dial; 1999; 15():193-6. PubMed ID: 10682100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.